HINGHAM, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) — Microbot Medical Inc. announces another important achievement. MBOcontinues to pursue its goal of expanding its global Intellectual Property (IP) portfolio for LIBERTY^® Robotic System as a grant for two design applications has been issued by the European Patent Office (EPO) covering the Robotic Drive and Remote Controllers of the LIBERTY Robotic System.

“The innovative nature of the LIBERTY robotic system continues to be recognized by global jurisdictions and is reflected in our continued ability to secure a sustainable competitive advantage through expanding our intellectual property portfolio,” commented Harel Gadot, Chairman, CEO and President. “This will allow us to continue leveraging our core competencies to support our vision of making robotics accessible and meeting the demands of physicians, hospitals and patients.”

About Microbot Medical

Microbot Medical Inc. MBO is a pre-clinical medical device company specializing in transformative micro-robotic technologies, primarily focused on natural and artificial lumens in the human body. Microbot’s current proprietary technological platforms form the basis for the development of a Multi-Generation Pipeline Portfolio (MGPP).

Microbot Medical was founded in 2010 by Harel Gadot, Prof. Moshe Shoham and Yossi Bornstein with the goal of improving clinical outcomes for patients and improving accessibility through the use of micro-robotic technologies. For more information on Microbot Medical, visit http://www.microbotmedical.com.

Safe haven

Statements regarding future financial and/or operating results, future growth in research, technology, clinical development and potential opportunities for Microbot Medical Inc. and its subsidiaries, together with other statements of management’s expectations, beliefs, goals, plans or prospects constitute forward-looking statements Statements within the meaning of Private Securities…